阿司匹林与克洛皮多格勒在急性冠状动脉综合征发生1个月后,有高出血风险或ST段升高
Yuki Obayashi1, Masahiro Natsuaki2, Hirotoshi Watanabe3
1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
JACC. Cardiovascular interventions
|June 5, 2025
概括
阿司匹林和克洛皮多格雷尔在经过皮肤冠状动脉干预后的急性冠状动脉综合征 (ACS) 患者的疗效和安全性相似. 这不管高出血风险 (HBR) 或ST段升高心肌梗塞 (STEMI) 状态如何,都是如此.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 高出血风险 (HBR) 和急性冠状动脉综合征 (ACS) 亚型,包括ST段升高心肌梗塞 (STEMI) 和非ST段升高ACS (NSTE-ACS),对于确定最佳抗血小板治疗至关重要.
- 选择正确的抗血小板策略对于经皮冠状动脉干预 (PCI) 后的ACS患者的管理至关重要.
研究的目的:
- 为了比较阿司匹林与克洛皮多格雷尔在接受PCI的ACS患者的1年疗效和安全性.
- 根据子组分析这些影响:高出血风险 (HBR) 与非HBR,STEMI与NSTE-ACS.
主要方法:
- 该研究分析了双抗血小板治疗-3 (STOPDAPT-3) 试验的短期和最佳持续时间的数据.
- 阿司匹林和克洛皮多格雷尔单疗法在PCI后超过30天至1年后进行了比较.
- 共同初级终点包括心血管事件 (死亡,心脏病发作,支架血栓,中风) 和严重出血 (BARC 3或5).
主要成果:
- 在HBR/非HBR或STEMI/NSTE-ACS小组中,在阿司匹林和克洛皮多格勒之间没有观察到心血管终点的统计学上显著差异.
- 同样,在这些患者分层中,两种抗血小板药物之间的出血终点率没有显著差异.
- 对心血管和出血终点的危险比率 (HR) 与HBR或ACS亚型没有显著的相互作用.
结论:
- 阿司匹林和克洛皮多格雷尔在ACS患者中显示出可比的心血管和出血结果,PCI后长达1年.
- 这些发现适用于不论高出血风险 (HBR) 状态或ACS亚型 (STEMI/NSTE-ACS).
- 该研究支持基于患者特异性风险因素的个性化抗血小板治疗决策.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.4K
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.4K
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
656
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
656
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
54
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
54
01:30Acute Coronary Syndrome I: Introduction
82
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
82
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932